chr11-124015675-T-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001004462.2(OR10G4):āc.101T>Gā(p.Val34Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000054 in 1,610,108 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001004462.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OR10G4 | NM_001004462.2 | c.101T>G | p.Val34Gly | missense_variant | 2/2 | ENST00000641722.1 | NP_001004462.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OR10G4 | ENST00000641722.1 | c.101T>G | p.Val34Gly | missense_variant | 2/2 | NM_001004462.2 | ENSP00000493036.1 | |||
OR10G4 | ENST00000641521.1 | c.101T>G | p.Val34Gly | missense_variant | 3/3 | ENSP00000493354.1 |
Frequencies
GnomAD3 genomes AF: 0.000118 AC: 18AN: 151914Hom.: 0 Cov.: 29
GnomAD3 exomes AF: 0.0000847 AC: 21AN: 247958Hom.: 0 AF XY: 0.0000672 AC XY: 9AN XY: 133922
GnomAD4 exome AF: 0.0000473 AC: 69AN: 1458076Hom.: 2 Cov.: 40 AF XY: 0.0000510 AC XY: 37AN XY: 725050
GnomAD4 genome AF: 0.000118 AC: 18AN: 152032Hom.: 0 Cov.: 29 AF XY: 0.000121 AC XY: 9AN XY: 74302
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 10, 2024 | The c.101T>G (p.V34G) alteration is located in exon 1 (coding exon 1) of the OR10G4 gene. This alteration results from a T to G substitution at nucleotide position 101, causing the valine (V) at amino acid position 34 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at